Literature DB >> 26278724

On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.

S E Rutstein1,2, C E Golin3, S B Wheeler1, D Kamwendo4, M C Hosseinipour2,4, M Weinberger1, W C Miller2,5, A K Biddle1, A Soko4, M Mkandawire6, R Mwenda7, A Sarr8, S Gupta8, R Mataya6.   

Abstract

Scale-up of viral load (VL) monitoring for HIV-infected patients on antiretroviral therapy (ART) is a priority in many resource-limited settings, and ART providers are critical to effective program implementation. We explored provider-perceived barriers and facilitators of VL monitoring. We interviewed all providers (n = 17) engaged in a public health evaluation of dried blood spots for VL monitoring at five ART clinics in Malawi. All ART clinics were housed within district hospitals. We grouped themes at patient, provider, facility, system, and policy levels. Providers emphasized their desire for improved ART monitoring strategies, and frustration in response to restrictive policies for determining which patients were eligible to receive VL monitoring. Although many providers pled for expansion of monitoring to include all persons on ART, regardless of time on ART, the most salient provider-perceived barrier to VL monitoring implementation was the pressure of work associated with monitoring activities. The work burden was exacerbated by inefficient data management systems, highlighting a critical interaction between provider-, facility-, and system-level factors. Lack of integration between laboratory and clinical systems complicated the process for alerting providers when results were available, and these communication gaps were intensified by poor facility connectivity. Centralized second-line ART distribution was also noted as a barrier: providers reported that the time and expenses required for patients to collect second-line ART frequently obstructed referral. However, provider empowerment emerged as an unexpected facilitator of VL monitoring. For many providers, this was the first time they used an objective marker of ART response to guide clinical management. Providers' knowledge of a patient's virological status increased confidence in adherence counseling and clinical decision-making. Results from our study provide unique insight into provider perceptions of VL monitoring and indicate the importance of policies responsive to individual and environmental challenges of VL monitoring program implementation. Findings may inform scale-up by helping policy-makers identify strategies to improve feasibility and sustainability of VL monitoring.

Entities:  

Keywords:  HIV; provider perceptions; resource-limited settings; viral load monitoring

Mesh:

Substances:

Year:  2015        PMID: 26278724      PMCID: PMC4834050          DOI: 10.1080/09540121.2015.1058896

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  32 in total

1.  Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.

Authors:  Bharat B Rewari; Damodar Bachani; Sikhamani Rajasekaran; Alaka Deshpande; Po Lin Chan; Padmini Srikantiah
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

2.  Measures of viral load using Abbott RealTime HIV-1 Assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals.

Authors:  Sarah E Rutstein; Deborah Kamwendo; Lebah Lugali; Isaac Thengolose; Gerald Tegha; Susan A Fiscus; Julie A E Nelson; Mina C Hosseinipour; Abdoulaye Sarr; Sundeep Gupta; Frank Chimbwandira; Reuben Mwenda; Ronald Mataya
Journal:  J Clin Virol       Date:  2014-05-22       Impact factor: 3.168

Review 3.  Patient needs and point-of-care requirements for HIV load testing in resource-limited settings.

Authors:  Martine Usdin; Martine Guillerm; Alexandra Calmy
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

Review 4.  Dried blood spots in HIV monitoring: applications in resource-limited settings.

Authors:  Asgeir Johannessen
Journal:  Bioanalysis       Date:  2010-11       Impact factor: 2.681

5.  HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.

Authors:  Douglas Krakower; Norma Ware; Jennifer A Mitty; Kevin Maloney; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-09

6.  Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

Authors:  Vincent C Marconi; Henry Sunpath; Zhigang Lu; Michelle Gordon; Kofi Koranteng-Apeagyei; Jane Hampton; Steve Carpenter; Janet Giddy; Douglas Ross; Helga Holst; Elena Losina; Bruce D Walker; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

7.  Dried blood spots for viral load monitoring in Malawi: feasible and effective.

Authors:  Sarah E Rutstein; Mina C Hosseinipour; Deborah Kamwendo; Alice Soko; Memory Mkandawire; Andrea K Biddle; William C Miller; Morris Weinberger; Stephanie B Wheeler; Abdoulaye Sarr; Sundeep Gupta; Frank Chimbwandira; Reuben Mwenda; Steve Kamiza; Irving Hoffman; Ronald Mataya
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 8.  Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy.

Authors:  Steven D Reid; Sarah J Fidler; Graham S Cooke
Journal:  Clin Epidemiol       Date:  2013-09-26       Impact factor: 4.790

9.  Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.

Authors:  Steven J Reynolds; Cissy Kityo; Frank Mbamanya; Robin Dewar; Francis Ssali; Thomas C Quinn; Peter Mugyenyi; Mark Dybul
Journal:  Antivir Ther       Date:  2009

Review 10.  Challenges and opportunities for the implementation of virological testing in resource-limited settings.

Authors:  Teri Roberts; Helen Bygrave; Emmanuel Fajardo; Nathan Ford
Journal:  J Int AIDS Soc       Date:  2012-10-09       Impact factor: 5.396

View more
  18 in total

1.  Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable.

Authors:  Sikhulile Moyo; Terence Mohammed; Kathleen E Wirth; Melanie Prague; Kara Bennett; Molly Pretorius Holme; Lucy Mupfumi; Philemon Sebogodi; Natasha O Moraka; Corretah Boleo; Comfort N Maphorisa; Boitumelo Seraise; Simani Gaseitsiwe; Rosemary M Musonda; Erik van Widenfelt; Kathleen M Powis; Tendani Gaolathe; Eric J Tchetgen Tchetgen; Joseph M Makhema; Max Essex; Shahin Lockman; Vladimir Novitsky
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

Review 2.  Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.

Authors:  Paul K Drain; Jienchi Dorward; Andrew Bender; Lorraine Lillis; Francesco Marinucci; Jilian Sacks; Anna Bershteyn; David S Boyle; Jonathan D Posner; Nigel Garrett
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

3.  Point-of-care HIV viral load and targeted drug resistance mutation testing versus standard care for Kenyan children on antiretroviral therapy (Opt4Kids): an open-label, randomised controlled trial.

Authors:  Rena C Patel; Patrick Oyaro; Katherine K Thomas; James Wagude; Irene Mukui; Evelyn Brown; Shukri A Hassan; Eunice Kinywa; Frederick Oluoch; Francesca Odhiambo; Boaz Oyaro; Leonard Kingwara; Enericah Karauki; Nashon Yongo; Lindah Otieno; Grace C John-Stewart; Lisa L Abuogi
Journal:  Lancet Child Adolesc Health       Date:  2022-08-18

4.  Adherence to viral load testing guidelines, barriers, and associated factors among persons living with HIV on ART in Southwestern Uganda: a mixed-methods study.

Authors:  Polly Lubega; Sylivia Juliet Nalugya; Angella Namyalo Kimuli; Majoreen Twinokusiima; Mercy Khasalamwa; Richard Kyomugisa; Jane Kabami; Asiphas Owaraganise
Journal:  BMC Public Health       Date:  2022-06-29       Impact factor: 4.135

5.  Towards the third 90: improving viral load testing with a simple quality improvement program in health facilities in Malawi.

Authors:  Julie Hubbard; Gift Kakwesa; Mike Nyirenda; James Mwambene; Ashley Bardon; Kelvin Balakasi; Kathryn Dovel; Thokozani Kalua; Risa M Hoffman
Journal:  Int Health       Date:  2019-05-01       Impact factor: 2.473

6.  Brief Report: Time to Repeat Viral Load Testing Among Unsuppressed Adolescents and Young Adults Living With HIV in Kenya.

Authors:  Cyrus Mugo; Alvin Onyango; Irene N Njuguna; Caren W Mburu; Barbra A Richardson; Laura Oyiengo; Irene Inwani; Grace John-Stewart; Dalton C Wamalwa; Pamela K Kohler
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-15       Impact factor: 3.731

7.  Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification: A laboratory assessment of 3 commercial assays.

Authors:  Pieter Pannus; Maarten Claus; Maria Mercedes Perez Gonzalez; Nathan Ford; Katrien Fransen
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 8.  Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review.

Authors:  Minh D Pham; Lorena Romero; Bruce Parnell; David A Anderson; Suzanne M Crowe; Stanley Luchters
Journal:  AIDS Res Ther       Date:  2017-01-19       Impact factor: 2.250

9.  Predictors of loss to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa.

Authors:  Rachel Arnesen; Anthony P Moll; Sheela V Shenoi
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

10.  Association of HIV/AIDS Clinician Warm Line Utilization with Diagnosis and Management of Antiretroviral Treatment Failure in Mozambique: A Retrospective Analysis of Program Data.

Authors:  Maria Ruano Camps; Paula E Brentlinger; Gerito Augusto; Alexandre Nguimfack; Florindo Mudender
Journal:  J Int Assoc Provid AIDS Care       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.